Targeted Biomarker Discovery by High Throughput Glycosylation Profiling of Human Plasma Alpha1-Antitrypsin and Immunoglobulin A

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Ruhaak, L Renee ^a   Koeleman, Carolien A M ^a   Uh, Hae Won ^a   Stam, Jord C ^b   van Heemst, Diana ^a   Maier, Andrea B ^a   Houwing Duistermaat, Jeanine J ^a   Hensbergen, Paul J ^a   Slagboom, P Eline ^a,c   Deelder, André M ^a   Wuhrer, Manfred ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Netherlands Consortium for Healthy Ageing   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 1 ANTITRYPSIN 1; ALPHA 1 ANTITRYPSIN 13; ALPHA 1 ANTITRYPSIN 14; ALPHA 1 ANTITRYPSIN 2; ALPHA 1 ANTITRYPSIN 4; ALPHA 1 ANTITRYPSIN 5; ALPHA 1 ANTITRYPSIN 6; ALPHA 1 ANTITRYPSIN 7; ALPHA 1 ANTITRYPSIN 9; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; GLYCAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN HEAVY CHAIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE MARKER; FEMALE; FLUORESCENCE ANALYSIS; GEL ELECTROPHORESIS; GLUCOSE BLOOD LEVEL; HIGH THROUGHPUT IMMUNO AFFINITY CAPTURING; HUMAN; IMMUNOLOGICAL PROCEDURES; INFLAMMATORY DISEASE; INSULIN BLOOD LEVEL; MALE; METABOLIC DISORDER; MICROTITER PLATE ASSAY; MULTIPLEXED CAPILLARY GEL ELECTROPHORESIS WITH LASER INDUCED FLUORESCENCE DETECTION; PROTEIN GLYCOSYLATION; PROTEOMICS; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; FEMALE; GLYCOPROTEINS; GLYCOSYLATION; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; IMMUNOGLOBULIN A; INFLAMMATION; LONGEVITY; MALE; POLYSACCHARIDES; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 84883611777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073082     Document Type: Article

References (57)

1. Shental-Bechor D, Levy Y, (2009) Folding of glycoproteins: toward understanding the biophysics of the glycosylation code. Curr Opin Struct Biol 19: 524-533.
2. Gu J, Sato Y, Kariya Y, Isaji T, Taniguchi N, et al. (2009) A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. J Proteome Res 8: 431-435.
3. Fukuda MN, Sasaki H, Lopez L, Fukuda M, (1989) Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood 73: 84-89.
4. Takahashi M, Kuroki Y, Ohtsubo K, Taniguchi N, (2009) Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res 344: 1387-1390.
5. Marth JD, Grewal PK, (2008) Mammalian glycosylation in immunity. Nat Rev Immunol 8: 874-887.
6. Ohtsubo K, Marth JD, (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126: 855-867.
7. Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, et al. (1997) The glycosylation of the complement regulatory protein, human erythrocyte CD59. J Biol Chem 272: 7229-7244.
8. Knezevic A, Polasek O, Gornik O, Rudan I, Campbell H, et al. (2009) Variability, Heritability and Environmental Determinants of Human Plasma N-Glycome. J Proteome Res 8: 694-701.
9. Arnold JN, Saldova R, Hamid UM, Rudd PM, (2008) Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 8: 3284-3293.
10. Gornik O, Wagner J, Pucic M, Knezevic A, Redzic I, et al. (2009) Stability of N-glycan profiles in human plasma. Glycobiology 19: 1547-1553.
11. Packer NH, von der Lieth CW, Aoki-Kinoshita KF, Lebrilla CB, Paulson JC, et al. (2008) Frontiers in glycomics: bioinformatics and biomarkers in disease. An NIH white paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11-13, 2006). Proteomics 8: 8-20.
12. Laroy W, Contreras R, Callewaert N, (2006) Glycome mapping on DNA sequencing equipment. Nat Protoc 1: 397-405.
13. Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, et al. (2008) HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 376: 1-12.
14. Ruhaak LR, Huhn C, Waterreus WJ, de Boer AR, Neususs C, et al. (2008) Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins. Anal Chem 80: 6119-6126.
15. Ruhaak LR, Uh HW, Beekman M, Hokke CH, Westendorp RG, et al. (2011) Plasma protein N-glycan profiles are associated with calendar age, familial longevity and health. J Proteome Res 10: 1667-1674.
16. Knezevic A, Gornik O, Polasek O, Pucic M, Redzic I, et al. (2010) Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 20: 959-969.
17. Vanhooren V, Liu XE, Franceschi C, Gao CF, Libert C, et al. (2009) N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing. Mech Ageing Dev 130: 92-97.
18. Poland DC, Schalkwijk CG, Stehouwer CD, Koeleman CA, van het HB, et al. (2001) Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function. Glycoconj J 18: 261-268.
19. Yang Z, Hancock WS, (2004) Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J Chromatogr A 1053: 79-88.
20. van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, et al. (2009) Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 11: R193.
21. Ruhaak LR, Uh HW, Beekman M, Koeleman CA, Hokke CH, et al. (2010) Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS ONE 5: e12566.
22. Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, et al. (2011) High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics 10: M111 010090.
23. Anderson NL, Anderson NG, (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1: 845-867.
24. Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Kohnlein T, et al. (2011) The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med 105: 1129-1139.
25. Yoo EM, Morrison SL, (2005) IgA: an immune glycoprotein. Clin Immunol 116: 3-10.
26. Deshpande N, Jensen PH, Packer NH, Kolarich D, (2010) GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. J Proteome Res 9: 1063-1075.
27. Torano A, Tsuzukida Y, Liu YSV, Putnam FW, (1977) Location and Structural Significance of Oligosaccharides in Human Iga1 and Iga2 Immunoglobulins. Proc Natl Acad Sci 74: 2301-2305.
28. Takahashi K, Smith AD, Poulsen K, Kilian M, Julian BA, et al. (2011) Naturally Occurring Structural Isomers in Serum IgA1 O-Glycosylation. J Proteome Res.
29. Gomes MM, Wall SB, Takahashi K, Novak J, Renfrow MB, et al. (2008) Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding. Biochemistry 47: 11285-11299.
30. Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, et al. (1998) The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions. J Biol Chem 273: 2260-2272.
31. Ferrarotti I, Thun GA, Zorzetto M, Ottaviani S, Imboden M, et al. (2012) Serum levels and genotype distribution of alpha1-antitrypsin in the general population. Thorax.
32. Karnaukhova E, Ophir Y, Golding B, (2006) Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use. Amino Acids 30: 317-332.
33. Kolarich D, Weber A, Turecek PL, Schwarz HP, Altmann F, (2006) Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics 6: 3369-3380.
34. Mills K, Mills PB, Clayton PT, Johnson AW, Whitehouse DB, et al. (2001) Identification of alpha(1)-antitrypsin variants in plasma with the use of proteomic technology. Clin Chem 47: 2012-2022.
35. Ruhaak LR, Hennig R, Huhn C, Borowiak M, Dolhain RJ, et al. (2010) Optimized workflow for preparation of APTS-labeled N-glycans allowing high-throughput analysis of human plasma glycomes using 48-channel multiplexed CGE-LIF. J Proteome Res 9: 6655-6664.
36. Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, et al. (2006) Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet 14: 79-84.
37. Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, et al. (1995) Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem 230: 229-238.
38. Ruhaak LR, Steenvoorden E, Koeleman CA, Deelder AM, Wuhrer M, (2010) 2-picoline-borane: a non-toxic reducing agent for oligosaccharide labeling by reductive amination. Proteomics 10: 2330-2336.
39. Skov T, van den Berg F, Tomasi G, Bro R (2006) Automated alignment of chromatographic data. Journal of Chemometrics 20 484-497.
40. Nielsen NPV, Carstensen JM, Smedsgaard J, (1998) Aligning of single and multiple wavelength chromatographic profiles for chemometric data analysis using correlation optimised warping. J Chromatogr A 805: 17-35.
41. Shikata K, Yasuda T, Takeuchi F, Konishi T, Nakata M, et al. (1998) Structural changes in the oligosaccharide moiety of human IgG with aging. Glycoconj J 15: 683-689.
42. Pepys MB, Hirschfield GM, (2003) C-reactive protein: a critical update. J Clin Invest 111: 1805-1812.
43. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, et al. (2007) Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 17: 1344-1356.
44. Takimori S, Shimaoka H, Furukawa J, Yamashita T, Amano M, et al. (2011) Alteration of the N-glycome of bovine milk glycoproteins during early lactation. FEBS J 278: 3769-3781.
45. Kronewitter SR, de Leoz ML, Peacock KS, McBride KR, An HJ, et al. (2010) Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J Proteome Res 9: 4952-4959.
46. Yamada E, Tsukamoto Y, Sasaki R, Yagyu K, Takahashi N, (1997) Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J 14: 401-405.
47. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T, (1988) Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 167: 1731-1736.
48. Westendorp RG, van Heemst D, Rozing MP, Frolich M, Mooijaart SP, et al. (2009) Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: The Leiden Longevity Study. J Am Geriatr Soc 57: 1634-1637.
49. Rozing MP, Westendorp RG, Frolich M, de Craen AJ, Beekman M, et al. (2009) Human insulin/IGF-1 and familial longevity at middle age. Aging (AlbanyNY) 1: 714-722.
50. Heijmans BT, Beekman M, Houwing-Duistermaat JJ, Cobain MR, Powell J, et al. (2006) Lipoprotein particle profiles mark familial and sporadic human longevity. PLoS Med 3: e495.
51. Su D, Zhao H, Xia H, (2010) Glycosylation-modified erythropoietin with improved half-life and biological activity. Int J Hematol 91: 238-244.
52. Sorensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, et al. (2009) Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood 114: 1645-1654.
53. Huhn C, Ruhaak LR, Wuhrer M, Deelder AM, (2012) Hexapeptide library as a universal tool for sample preparation in protein glycosylation analysis. J Proteomics 75: 1515-1528.
54. Wada Y, Tajiri M, Ohshima S, (2010) Quantitation of saccharide compositions of O-glycans by mass spectrometry of glycopeptides and its application to rheumatoid arthritis. J Proteome Res 9: 1367-1373.
55. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, et al. (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316: 452-457.
56. van Zeben D, Rook GA, Hazes JM, Zwinderman AH, Zhang Y, et al. (1994) Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study. Br J Rheumatol 33: 36-43.
57. Field MC, matayakul-Chantler S, Rademacher TW, Rudd PM, Dwek RA, (1994) Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis. Biochem J 299 (Pt 1): 261-275.